Genetic Clues for Skin Cancer Therapies Hollis NY

Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.

Local Companies

Alan Glass
(212) 247-7546
250 W 57Th St # 1231-2
New York, NY
Stephen L Comite
(212) 557-2600
104 E 40Th St # 402
New York, NY
Marc R Avram
(212) 734-4007
927 5Th Ave # 1
New York, NY
Barbara Lukash, MD
914-712-2800
14 Lawton Street
New Rochelle, NY
Eve Lupenko
(516) 747-7778
229 Seventh Street, Suite 105
Garden City, NY
Arthur Katz
(201) 653-5555
2954 John F Kennedy Blvd
Jersey City, NJ
Charles Halasz
(212) 305-0505
161 Fort Washington Ave Irving Pavillion 12Th
New York, NY
Ellis Gottesfeld
(212) 721-4614
185 West End Avenue Suite 1D
New York, NY
Philip Bruder
(212) 980-9292
245 E 63Rd St # 107
New York, NY
Norman J Goldfarb
(516) 487-8190
20 Canterbury Rd Apt 3K
Great Neck, NY
Data Provided by:
  

Provided By:

MONDAY, Aug. 31 (HealthDay News) -- Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations.

Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma. Their study is published in the September issue of the journal Nature Genetics.

"We have found what appears to be an Achilles' heel of a sizable share of melanomas," Samuels, an investigator in the cancer genetics branch of the institute's Division of Intramural Research, said in a NIH news release.

The PTK family includes many genes that, when mutated, promote many types of cancer, including brain, gastric and lung malignancies, according to background information provided in the news release. In the new NIH study, one PTK gene that appeared particularly suspicious was the ERBB4 gene. Scientists found ERBB4 mutations in 19 percent of patients' tumors, making it the most frequently mutated PTK gene in melanoma. Additional lab studies found that melanoma cells with the ERBB4 defect were dependent on the mutant gene for their growth.

The researchers also found that two additional PTK genes -- FLT1 and PTK2B -- were mutated in about 10 percent of the tumor samples.

The discoveries could open up new avenues for therapies. For example, the researchers discovered that melanoma cells grew much more slowly when exposed to lapatinib (Tykerb), a chemotherapy drug that inhibits ERBB4. Lapatinib is already in use by some breast cancer patients. The NIH team is planning a clinical trial using lapatinib in patients with metastatic melanoma harboring ERBB4 mutations.

"Though additional work is needed to gain a more complete understanding of these genetic mutations and their roles in cancer biology, our findings open the door to pursuing specific therapies that may prove useful for the treatment of melanoma with ERBB4 mutations," Samuels stated.

More information

The American Cancer Society has more on melanoma.

SOURCE: U.S. National Institutes of Health, news release, Aug. 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Risk Factors for Squamous Cell Cancer of the Skin Hollis NY
Squamous cell carcinoma of the skin has multiple risk factors, but the greatest risk factor is sun exposure. Sun: For those who have a long history of sun exposure, the risk of SCC is very high. Individuals who have lived in the Southern USA have a greater chance of developing SCC than those who live in the Northern parts of the country. Worldwide, SCC is again more common in the sunny areas.
- High Levels of Selenium Decreases Incidence of Skin Cancer. Hollis NY
- Getting a Botox Cosmetic Injection Hollis NY
- Healing Facial Spider Veins Hollis NY
- Delayed Prostate Cancer Therapy Hollis NY
- Filling in Wrinkles with Dermal Fillers Hollis NY
- Risks for Childhood Cancer Survivors Hollis NY
- Gene Mutation in Dogs Hollis NY
- Breast Cancer Treatment Hollis NY
- Follow Up After Skin Cancer Hollis NY